Schistosomicidal effect of the anti-inflammatory drug diclofenac and its structural correlation with praziquantel

International Journal of Antimicrobial Agents

Volumn 44, Issue 4, 2014, Pages 372-374

  Carvalho, Aline A L ^a   Mafud, Ana C ^b   Pinto, Pedro L S ^c   Mascarenhas, Yvonne P ^b   De Moraes, Josué ^a  

^a Research Center for Neglected Diseases Faculty of Science of Guarulhos FACIG UNIESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; PRAZIQUANTEL; ANTHELMINTIC AGENT; ANTIINFLAMMATORY AGENT;

ANTIMICROBIAL ACTIVITY; CORRELATIONAL STUDY; DRUG STRUCTURE; INFECTION CONTROL; LETTER; NONHUMAN; PARASITE SURVIVAL; PRIORITY JOURNAL; SCHISTOSOMIASIS; SCHISTOSOMIASIS MANSONI; SCHISTOSOMICIDAL ACTIVITY; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; MOUSE; SCHISTOSOMA; SURVIVAL;

ANIMALS; ANTHELMINTICS; ANTI-INFLAMMATORY AGENTS; DICLOFENAC; MICE; MODELS, MOLECULAR; PRAZIQUANTEL; SCHISTOSOMA; SURVIVAL ANALYSIS;

EID: 84925384348     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.06.018     Document Type: Letter

References (5)

1. B. Gryseels, K. Polman, J. Clerinx, and L. Kestens Human schistosomiasis Lancet 368 2006 1106 1118
2. J. Moraes Antischistosomal natural compounds: present challenges for new drug screens A.J. Rodriguez-Morales, Current topics in tropical medicine 2012 InTech Rijeka, Croatia 333 358
3. N.G. Nessim, and S. Mahmoud Prophylactic effect of the anti-inflammatory drug diclofenac in experimental schistosomiasis mansoni Int J Infect Dis 11 2007 161 165
4. J. de Moraes, R.N. de Oliveira, J.P. Costa, A.L. Junior, D.P. de Sousa, and R.M. Freitas Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease Schistosomiasis mansoni PLoS Negl Trop Dis 8 2014 e2617
5. P. Hernández, R. Rojas, R.H. Gilman, M. Sauvain, L.M. Lima, and E.J. Barreiro Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates Eur J Med Chem 59 2013 64 74